Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: An Ivy Foundation Early Phase Clinical Trials Consortium phase II study

Nicholas Butowski, Howard Colman, John F. De Groot, Antonio M. Omuro, Lakshmi Nayak, Patrick Y. Wen, Timothy F. Cloughesy, Adhirai Marimuthu, Sam Haidar, Arie Perry, Jason Huse, Joanna Phillips, Brian L. West, Keith B. Nolop, Henry H. Hsu, Keith L. Ligon, Annette M. Molinaro, Michael Prados

Research output: Contribution to journal › Article › peer-review

405 Scopus citations

Fingerprint

Dive into the research topics of 'Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: An Ivy Foundation Early Phase Clinical Trials Consortium phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences